THE PROJECT ALS MISSION
Project ALS identifies and funds the most promising scientific research that will lead to the first effective treatments and a cure for ALS. We recruit the world’s best scientists and doctors to work together—rationally and aggressively—to develop a better understanding of the ALS disease process and, in parallel, better therapeutic strategies.
Project ALS is the world’s first ALS organization to focus exclusively on research. We have raised over $100 million in 22 years to fund ALS research programs at leading academic institutions including Harvard University, Columbia University, UCSF, and the Salk Institute, and have made significant progress toward a cure for ALS.
Read about the latest updates and breakthroughs in ALS research, and see the Project ALS research philosophy – something we’re proud to say has accelerated the pace of research.
Read more about Amylyx, the Core, and the Power of Collaboration here: ID: Project ALS director of research Valerie Estess w/ co-scientific directors of the Core, Serge Przedborski & Hynek Wichterle at the first recorded brainstorming meeting of the CoreRead More
Project ALS is encouraged by this news & by Amylyx's collaborative approach to ALS drug development. In 2017, Amylyx were our first industry partners at the Core & AMX0035's rapid development proves that when drug developers work with the ALS community, treatments move faster...Read More
On Wednesday, Amylyx Pharmaceuticals announced that they are planning to file a New Drug Application—the formal submission for a drug to be approved by the FDA—for their investigational drug, AMX0035, for the treatment of ALS by the end of the year...Read More